BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15956690)

  • 1. Genetic targeting of relaxin and insl3 signaling in mice.
    Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
    Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic targeting of relaxin and insulin-like factor 3 receptors in mice.
    Kamat AA; Feng S; Bogatcheva NV; Truong A; Bishop CE; Agoulnik AI
    Endocrinology; 2004 Oct; 145(10):4712-20. PubMed ID: 15256493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine effects of relaxin overexpression in mice.
    Feng S; Bogatcheva NV; Kamat AA; Truong A; Agoulnik AI
    Endocrinology; 2006 Jan; 147(1):407-14. PubMed ID: 16223865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent.
    Kumagai J; Hsu SY; Matsumi H; Roh JS; Fu P; Wade JD; Bathgate RA; Hsueh AJ
    J Biol Chem; 2002 Aug; 277(35):31283-6. PubMed ID: 12114498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GREAT/LGR8 is the only receptor for insulin-like 3 peptide.
    Bogatcheva NV; Truong A; Feng S; Engel W; Adham IM; Agoulnik AI
    Mol Endocrinol; 2003 Dec; 17(12):2639-46. PubMed ID: 12933905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the LGR8 residues involved in binding insulin-like peptide 3.
    Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA
    Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxin, the relaxin-like factor and their receptors.
    Schwabe C; Büllesbach EE
    Adv Exp Med Biol; 2007; 612():14-25. PubMed ID: 18161478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxin research in the postgenomic era.
    Kawamura K; Sudo S; Kumagai J; Pisarska M; Hsu SY; Bathgate R; Wade J; Hsueh AJ
    Ann N Y Acad Sci; 2005 May; 1041():1-7. PubMed ID: 15956679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.
    Muda M; He C; Martini PG; Ferraro T; Layfield S; Taylor D; Chevrier C; Schweickhardt R; Kelton C; Ryan PL; Bathgate RA
    Mol Hum Reprod; 2005 Aug; 11(8):591-600. PubMed ID: 16051677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo.
    Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD
    Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGR7-truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro.
    Scott DJ; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():22-6. PubMed ID: 15956683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin receptors in hepatic stellate cells and cirrhotic liver.
    Bennett RG; Dalton SR; Mahan KJ; Gentry-Nielsen MJ; Hamel FG; Tuma DJ
    Biochem Pharmacol; 2007 Apr; 73(7):1033-40. PubMed ID: 17214975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
    Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ
    Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin signaling in reproductive tissues.
    Hsu SY; Nakabayashi K; Nishi S; Kumagai J; Kudo M; Bathgate RA; Sherwood OD; Hsueh AJ
    Mol Cell Endocrinol; 2003 Apr; 202(1-2):165-70. PubMed ID: 12770746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the rat INSL3 receptor.
    Scott DJ; Fu P; Shen PJ; Gundlach A; Layfield S; Riesewijk A; Tomiyama H; Hutson JM; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():13-6. PubMed ID: 15956681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.
    Yan Y; Cai J; Fu P; Layfield S; Ferraro T; Kumagai J; Sudo S; Tang JG; Giannakis E; Tregear GW; Wade JD; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():35-9. PubMed ID: 15956685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue.
    Bennett RG; Mahan KJ; Gentry-Nielsen MJ; Tuma DJ
    Ann N Y Acad Sci; 2005 May; 1041():185-9. PubMed ID: 15956705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways of the LGR7 and LGR8 receptors determined by reporter genes.
    Halls ML; Bathgate RA; Roche PJ; Summers RJ
    Ann N Y Acad Sci; 2005 May; 1041():292-5. PubMed ID: 15956720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2.
    Sudo S; Kumagai J; Nishi S; Layfield S; Ferraro T; Bathgate RA; Hsueh AJ
    J Biol Chem; 2003 Mar; 278(10):7855-62. PubMed ID: 12506116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.